- Conditions
- Epinephrine Causing Adverse Effects in Therapeutic Use
- Interventions
- HemeRX epinephrine pellets
- Drug
- Lead sponsor
- University of Washington
- Other
- Eligibility
- 2 Years to 9 Years
- Enrollment
- 13 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- Seattle, Washington
Source: ClinicalTrials.gov public record
Updated May 12, 2021 · Synced May 22, 2026, 4:14 AM EDT